Mike Grey

(Mr. Michael Grey)

Currently holds positions in Spruce Biosciences Inc, Biomarin Pharmaceutical Inc, Mirati Therapeutics Inc and Horizon Therapeutics PLC

Positions
Position Company Period
Chairman of the Board Spruce Biosciences Inc Jan. 1, 2016 -
Independent Director Biomarin Pharmaceutical Inc Dec. 15, 2005 -
Independent Director Mirati Therapeutics Inc Nov. 5, 2014 -
Lead Independent Director Horizon Therapeutics PLC Aug. 1, 2012 -
Independent Director Horizon Therapeutics PLC Sept. 1, 2011 - Aug. 1, 2012
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-06-09 2023-06-08
PS Planned sale
14,608 -100.0%
29.00
423,632 USD 		14,608 -100.0% 29.00 423,632 USD
2023-05-04 2023-05-03
PS Planned sale
14,608 -100.0%
28.00
409,024 USD 		14,608 -100.0% 28.00 409,024 USD
2021-07-23 2021-07-22
PS Planned sale
4,000 -100.0%
100.05
400,200 USD 		4,000 -100.0% 100.05 400,200 USD
2021-07-23 2021-07-22
PS Planned sale
1,000 -20.0%
100.00
100,000 USD 		1,000 -20.0% 100.00 100,000 USD
2021-03-09 2021-03-05
S Sale
5,000 -10.5%
76.28
381,400 USD 		5,000 -10.5% 76.28 381,400 USD
2020-12-16 2020-12-14
PS Planned sale
89 -2.0%
249.42
22,198 USD 		89 -2.0% 249.42 22,198 USD
2020-12-16 2020-12-14
PS Planned sale
1,019 -19.0%
248.55
253,269 USD 		1,019 -19.0% 248.55 253,269 USD
2020-12-16 2020-12-14
PS Planned sale
1,997 -27.1%
247.62
494,502 USD 		1,997 -27.1% 247.62 494,502 USD
2020-12-16 2020-12-14
PS Planned sale
1,807 -19.7%
246.73
445,834 USD 		1,807 -19.7% 246.73 445,834 USD
2020-12-16 2020-12-14
PS Planned sale
1,284 -12.3%
245.11
314,725 USD 		1,284 -12.3% 245.11 314,725 USD
2020-12-16 2020-12-14
PS Planned sale
1,653 -13.7%
244.45
404,083 USD 		1,653 -13.7% 244.45 404,083 USD
2020-12-16 2020-12-14
PS Planned sale
1,815 -13.0%
243.35
441,671 USD 		1,815 -13.0% 243.35 441,671 USD
2020-12-16 2020-12-14
PS Planned sale
857 -5.8%
242.29
207,641 USD 		857 -5.8% 242.29 207,641 USD
2020-12-16 2020-12-14
PS Planned sale
379 -2.5%
241.22
91,422 USD 		379 -2.5% 241.22 91,422 USD
2020-08-07 2020-08-05
PS Planned sale
1,755 -100.0%
73.35
128,729 USD 		1,755 -100.0% 73.35 128,729 USD
2020-08-05 2020-08-03
PS Planned sale
2,500 -5.5%
120.35
300,875 USD 		2,500 -5.5% 120.35 300,875 USD
2020-07-22 2020-07-22
PS Planned sale
1,755 -100.0%
60.00
105,300 USD 		1,755 -100.0% 60.00 105,300 USD
2020-06-26 2020-06-25
PS Planned sale
1,755 -100.0%
55.00
96,525 USD 		1,755 -100.0% 55.00 96,525 USD
2020-05-26 2020-05-22
S Sale
10,530 -100.0%
48.77
513,505 USD 		10,530 -100.0% 48.77 513,505 USD
2019-11-14 2019-11-12
PS Planned sale
3,042 -57.4%
102.44
311,622 USD 		3,042 -57.4% 102.44 311,622 USD
2019-05-15 2019-05-13
PS Planned sale
300 -18.3%
66.08
19,825 USD 		300 -18.3% 66.08 19,825 USD
2019-05-15 2019-05-13
PS Planned sale
5,460 -76.9%
65.26
356,314 USD 		5,460 -76.9% 65.26 356,314 USD
2016-02-23 2016-02-22
PS Planned sale
7,500 -22.2%
80.00
600,000 USD 		7,500 -22.2% 80.00 600,000 USD